UNSPSC 51284713: Stallimycin hydrochloride

This classification denotes a distamycin antibiotic and dna minor groove binding agent with the molecular formula C22H27N9O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F6010N240F, chemically known as distamycin a, hydrochloride but more generally known as stallimycin hydrochloride, which bears US NIH Compound Identifier 3115. Most nations, for tariff and trade purposes, schedule stallimycin hydrochloride under HS 29419000. As of Q4 2014, STALLIMYCIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.

SMILES: CN1CC(CC1C(=O)NC2CC(N(C2)C)C(=O)NC3CC(N(C3)C)C(=O)NCCC(=N)N)NC=O.CL.

UNSPSC 51284713 Stallimycin hydrochloride is a Commodity code covering pharmaceutical products procured by state and local health agencies. Recent activity in the code shows little direct alignment with stallimycin itself; instead, state and local governments are buying related antibiotic and emergency-response pharmaceutical products through cooperative purchasing vehicles and competitive bid processes. The Illinois Department of Public Health and Seminole County, Florida have posted and awarded contracts for pharmaceutical supplies including doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone through piggyback arrangements and traditional invitations for bid. Issuing bodies under this code span state health departments and county health services. Cooperative purchasing consortiums such as MMCAP Infuse serve as aggregation mechanisms for multi-year pharmaceutical supply agreements, with contract terms typically spanning 12 to 36 months and renewal options built in.

Recent opportunities show activity concentrated in Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets valued at $2,999,999.11 over the contract life under Solicitation Number 26482DPHPREPDB53392, with an initial 12-month term and two optional renewal years. Seminole County, Florida issued an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with bids due July 26, 2023, and a two-year initial term plus one-year renewal option. Vendors responding to county and state health procurements under this code must meet E-Verify and drug-free workplace certifications; when FEMA funding is involved, federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act apply.